Friday 6 November 2026 Export NVS’s income statement to Excel — free account

Novartis AG

NVS Healthcare Drug Manufacturers General

Novartis AG’s revenue for fiscal 2025 (year ended December 2025) was $56.7 billion, up 9.57% from fiscal 2024.

Revenue: +4.67%
EPS: −69.1%
Free cash flow: −17.8%
Total debt: +53.9%

Quarter to September 2026, against a year earlier

160.96 0.97 −0.60%

Follow NVS

Alert me

Market cap: $296.4B
P/E: 30.9×
Fwd P/E: 23.2×
Dividend yield: 2.93%
F-score: 8/9
Altman Z: 4.13
Beneish M: −2.49
Dividend safety: 66/100

Overview

Novartis AG (NVS) P/E ratio

Alert me on P/E ratio

As of 5 November 2026, Novartis AG (NVS) trades at a P/E ratio of 30.9×. Over the past ten years it has ranged from 7.0× (September 2022) to 31.4× (November 2026); the current reading is higher than 100% of that period. That is above the Drug Manufacturers General industry median of 26.6× and above the Healthcare sector median of 25.2×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/NVS/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Novartis AG P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/NVS/metrics/pe-ratio">Novartis AG (NVS) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	19.1×	16.30%
FY2024	16.5×	17.21%
FY2023	14.0×	(49.77%)
FY2022	28.0×	254.28%
FY2021	7.9×	(69.32%)
FY2020	25.7×	43.54%
FY2019	17.9×	17.27%
FY2018	15.3×	(38.79%)
FY2017	25.0×	(0.04%)
FY2016	25.0×	139.49%

Period	P/E ratio	Change
Sep 2026	27.2×	15.39%
Jun 2026	23.5×	8.14%
Mar 2026	21.8×	13.63%
Dec 2025	19.1×	9.90%
43 more quarters	Free account

Against its own ten years

Low 7.0× High 31.4×

Ten-year median 18.4×

Current reading's percentile 100

Company	P/E ratio
GILD Gilead Sciences, Inc. compare	n/m
NVO Novo Nordisk A/S compare	9.9×
AZN AstraZeneca PLC compare	26.3×
AMGN Amgen Inc. compare	26.6×
NVS Novartis AG	30.9×
JNJ Johnson & Johnson compare	41.3×
PFE Pfizer Inc. compare	42.2×
ABBV AbbVie Inc. compare	49.7×
MRK Merck & Co., Inc. compare	118×
Drug Manufacturers General industry median	26.6×
Healthcare sector median	25.2×
Market median	17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

Novartis AG (NVS) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on NVS

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on NVS

Stockrow Weekly